Analytical Data
-
Gene name
FAM131A
- Application
-
Alternative Names
FAM131A；C3orf40；Protein FAM131A
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6UXB0
-
Expression Region
1-281aa
-
AA Sequence
MLPKSRRALTIQEIAALARSSLHGISQVVKDHVTKPTAMAQGRVAHLIEWKGWSKPSDSPAALESAFSSYSDLSEGEQEARFAAGVAEQFAIAEAKLRAWSSVDGEDSTDDSYDEDFAGGMDTDMAGQLPLGPHLQDLFTGHRFSRPVRQGSVEPESDCSQTVSPDTLCSSLCSLEDGLLGSPARLASQLLGDELLLAKLPPSRESAFRSLGPLEAQDSLYNSPLTESCLSPAEEEPAPCKDCQPLCPPLTGSWERQRQASDLASSGVVSLDEDEAEPEEQ
-
Molecular Weight
61.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM131A, or Family with Sequence Similarity 131 Member A, is a protein that has garnered attention in the field of molecular biology due to its potential role in various cellular processes, including signal transduction and cellular responses to stress. Recent studies have suggested that FAM131A may be involved in regulating immune responses and may have implications in cancer progression, as it is associated with pathways that modulate inflammation and cell survival. The recombinant protein of FAM131A is essential for exploring its biological functions and mechanisms of action in vitro and in vivo. Researchers aim to produce this protein using techniques such as recombinant DNA technology to facilitate detailed studies, including its interactions with other proteins, its impact on cellular pathways, and its potential as a therapeutic target. Understanding the structure and function of recombinant FAM131A can provide insights into its roles in health and disease, paving the way for novel therapeutic strategies and contributing to the broader understanding of molecular signaling networks. Overall, the investigation of FAM131A and its recombinant form is critical for elucidating its biological significance and therapeutic potential, highlighting the importance of further research in this area.
